★ Immunology IBD Quiz
What was the primary endpoint for both the UNITI-1 and UNITI-2 studies?
A. CDAI-70 response at Week 8
B. CDAI-90 response at Week 6 and clinical response at Week 6
C. Clinical response at Week 6
D. Clinical remission at Week 8
Preview next quiz:
Which biologic consists of Human p75 TNF receptor
A. Secukinumab
B. Abatacept
C. Etanercept
D. Adalimumab
Disclaimer:
Medical Quiz should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. All content on this website is for informational and educational purposes only.